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1. Introduction 
Genome-wide association studies (GWAS) have become a popular method of surveying 
haplotype variations within populations. The recent explosion and success of these studies 
has allowed for identification of multiple gene variations and non-genetic risk factors that 
are often involved in pathogenesis of many diseases (Xavier&Rioux, 2008). Efforts to archive 
these single nucleotide polymorphisms (SNPs) and make the information publicly available 
have been made possible by the International Haplotype Map Project (HapMap) (The 
International HapMap Consortium, 2005; The International HapMap Consortium, 2007) and 
development of GWAS databases (Johnson&O'Donnell, 2009) such as Genomes.gov 
(Hindorff et al., 2009). The HapMap database of genetic variants and the ever progressing 
technology involved in identifying genetic disease susceptibility markers has allowed for 
identification of shared genetic associations that were undetectable with previous methods 
for identifying deleterious mutations effects for individual genes (Xavier&Rioux, 2008). We 
are now capable of detecting common susceptibility markers between previously 
unassociated diseases with the ability to assess combined association signals shared by 
biological pathways (Wang et al., 2011). 
Research of immune-mediated disease susceptibility has benefited from the discovery of 
shared haplotypes. GWAS with a focus on autoimmune diseases, which included celiac 
disease, Crohn’s disease, multiple sclerosis, rheumatoid arthritis, systemic lupus 
erythematosus, and type 1 diabetes (Lettre&Rioux, 2008), have shed light on shared genetic 
markers. Such markers can be exploited to identify biomedical traits that translate to 
improved diagnostic and treatment techniques (McCarthy et al., 2008). Under the common 
disease/common variant hypothesis (Wang et al., 2005), one would assume that shared 
variants result in shared disease phenotypes, and this commonality could serve as a global 
target for effective treatment options. It is under this assumption that many disease 
association studies are conducted. The Wellcome Trust Case Control Consortium (WTCCC) 
conducted a study in which nearly 2000 individuals were examined for coronary artery 
disease (CAD), hypertension, type II diabetes (T2D), rheumatoid arthritis (RA), Crohn’s 
disease (CD), type I diabetes (T1D) and bipolar disorder (BD) susceptibility against a shared 
set of about 3000 controls (The Wellcome Trust Case Control Consortium, 2007). The study 
revealed several association loci for the seven diseases, with some of these indicating risk for 
more than one of the studied diseases (The Wellcome Trust Case Control Consortium, 2007). 
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Huang et al. used the data from the WTCCC study to see if associations could be made 
between the seven diseases given the loci and collections of other data regarding disease 
susceptibility (Huang et al., 2009). Huang et al. performed analyses at four levels 
(nucleotide, gene, protein, and phenotype) to determine the existence of overlap across 
SNPs associated with the seven diseases and constructed protein-protein interaction 
networks to visualize similarities between diseases (Huang et al., 2009). The group found 
strong associations across all four levels of analysis for the autoimmune group (CD, RA, and 
T1D), while no genetic associations were found at any level within the 
metabolic/cardiovascular group (CAD, hypertension and T2D) (Huang et al., 2009). These 
results reasserted some expectations derived from clinical literature in the case of the 
autoimmune group, and suggested inappropriate disease grouping in the case of the 
metabolic/cardiovascular group (Huang et al., 2009). 
For this study, we proposed a large-scale disease and phenotype comparison based on the 
WTCCC and Huang et al. studies. To this end, we have combined data from GWAS with 
expression pattern data to determine if genetic and expression similarities exist between 
diseases. A total of 61 human diseases and phenotypes were assessed. Disease relatedness 
networks (DRNs) were constructed to visually assess associations on a larger scale. We also 
took advantage of high-throughput molecular assay technologies to incorporate mRNA 
expression profiles of diseases, and thus added another dimension of analysis toward 
assessing disease relationships. Gene expression is an indicator of cellular state, and gene 
expression profiles can be considered as quantitative traits that are highly heritable. The link 
between organismal complex traits, such as disease-related phenotype, and gene expression 
variation has been theoretically accepted (Goring et al., 2007; Moffatt et al., 2007; Chen et al., 
2008; Emilsson et al., 2008). With the declining per-sample costs of high-throughput 
microarray experiments, the amount of gene expression data in international repositories 
has grown exponentially. The availability of these datasets for many different diseases 
provides an opportunity to use data-driven approaches to improve our understanding of 
disease relationships. Hu and Agarwal (Hu&P., 2009) determined disease-disease and 
disease-drug networks using large-scale gene expression data. Very recently, Suthram et al. 
(Suthram et al., 2010) presented a quantitative framework to compare and contrast diseases 
by combining both disease-related mRNA expression data and human protein interaction 
data. Although GWAS provide comprehensive views of disease interrelationships at the 
DNA level, the insights from the gene expression aspect, which reflects cellular phenotype, 
will further advance and strengthen the understanding of this issue. A large-scale disease 
comparison study such as this has the potential to uncover relationships between diseases 
and phenotypes that are often overlooked in single disease SNP data analysis. 
2. Methods 
2.1 SNP-based genetic analysis 
Five populations were considered for this expansion study: Han Chinese (CHB), Japanese 
(JPT), a combined CHB and JPT population (CHB+JPT), Yoruba (YRI), and U.S. residents 
with northern and western European ancestry (CEU). SNP dataset 2009-02_rel24 (The 
International HapMap Consortium, 2005; The International HapMap Consortium, 2007) was 
downloaded from the HapMap site and the SNP set was expanded by means of linkage 
disequilibrium (LD). SNPs with an r2 greater than or equal to 0.5 were included. SNPs were 
divided by associated disease or phenotype (listed in Table 1) and the divisions were 
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maintained for each succeeding level of analysis. SNPs were divided into blocks based on an 
r2 greater than or equal to 0.1. Gene names from Ensembl (Birney et al., 2004) were assigned 
to blocks if the genetic location was within 2 kilobases up- or downstream of the gene of 
interest or within the start and end bases for the gene. Gene data were cross-referenced 
against pathway-specific gene lists generated from the KEGG database (Kanehisa&Goto, 
2000; Kanehisa et al., 2006; Kanehisa et al., 2010) in order to assign genes to identified 
pathways. Pairwise comparisons for each level were conducted to see if diseases and 
phenotpyes shared SNPs, blocks, genes, or pathway designations. Jaccard index values were 
calculated for each comparison at each level to assess similarity. Using the Jaccard indexes, 
DRNs were constructed to visualize the strength of relatedness between diseases. DRNs 
were visually inspected to identify the strongest relationships. Suggested associations were 
verified by principal components analysis (PCA) and minor data mining for clinical 
relevance. Complete details of these methods were previously described by Lewis et al 
(Lewis et al., 2011). 
2.2 Gene expression dataset 
The gene expression data used in this analysis was obtained from the NCBI Gene 
Expression Omnibus (GEO) (Barrett et al., 2009). Not all of the 61 diseases were represented 
by expression data on the GEO site. Data for a subset of diseases was found by scanning the 
experimental context of a collection of GEO data (or GEO Series, GSE) for microarrays that 
were assigned to human disease conditions. Only those microarrays that were curated and 
reported in the GEO Datasets (or GDS) were used in our analysis. The data set was also 
restricted to those GSEs in which both the disease and the corresponding control condition 
(from healthy tissue samples) were measured in the same tissue.  For consistency, we 
further restricted the GSEs to only those datasets which used Affymetrix Gene Chip Human 
Genome U133 Array Set HG-U133A (GPL96), HG-U133B (GPL97) and HG-U133plus2 
(GPL570), which are among the most commonly used platforms. Probes for these platforms 
were mapped to the current gene identifiers (Chen et al., 2007). This process yielded 
nineteen diseases for the final GEO analysis. 
2.3 Expression measurement 
To quantitatively compare expression data, we first normalized the data in each microarray 
sample using the Z-score transformation to make the expression values across various 
microarray samples and diseases comparable. Next, we performed an unpaired two-sample 
Student t-test to compute the t-test statistic and p-value of each gene between the disease 
and control groups. We only used the most appropriate Affymetrix probe set in which a 
single probe was representative of each gene. The most appropriate Affymetrix probe set 
was adopted from the work of Hu et al. (Hu&Agarwal, 2009) as many genes were 
represented by multiple probe sets in Affymetrix U133 microarray chips. This modification 
avoided correlation and scoring biases brought on by over-representation of those genes. 
18,600 most appropriate probes/genes for each of nineteen diseases were identified. The 
genes were grouped with statistically significant high t-test statistics (p<0.05) as “up-
regulated genes” and statistically significant low t-test statistics (p<0.05) as “down-regulated 
genes”. Instead of using a p-value threshold as a cutoff to identify significantly changed 
genes, the 200 and 1000 most changed genes were designated as the disease-associated 
significantly changed genes for each disease state. The lowest p-values in each category 
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 Abbre-
viation 
Disease/ 
Phenotype
Abbre-
viation
Disease/ 
Phenotype
Abbre-
viation
Disease/ 
Phenotype
Abbre-
viation
Disease/ 
Phenotype 
AD 
Alzheimer's 
disease 
EO 
Early onset 
extreme obesity
LM 
Lipid 
measurements
QT 
Cardiac 
repolarization 
(QT interval) 
AF 
Atrial 
Fibrillation/At
-rial Flutter 
GCA 
General 
cognitive 
ability
LOAD 
Late-onset 
Alzheimer's 
disease
RA 
Rheumatoid 
Arthritis 
ALS 
Amyotrophic 
Lateral 
Sclerosis 
GD 
Gallstone 
disease 
LONG 
Longevity and 
age-related 
phenotypes
RLS 
Restless Leg 
Syndrome 
BA Brain aging GLA Glaucoma MHA 
Minor 
histocompat-
ibility 
antigenicity
SA 
Subclinical 
atherosclerosis 
BC Breast cancer HAE 
Hepatic 
adverse events 
with thrombin 
inhibitor 
ximelagatran
MI 
Myocardial 
infarction 
SALS 
Sporadic 
Amyotrophic 
lateral Sclerosis 
BD 
Bipolar 
disorder 
HBF 
Adult fetal 
hemoglobin 
levels (HbF) by 
F cell levels
MS 
Multiple 
sclerosis 
SCP 
Sleep and 
circadian 
phenotypes 
BL Blood lipids HEI Height ND 
Nicotine 
dependence
SLCL 
Serum LDL 
cholesterol levels 
BMG 
Bone mass 
and geometry
HEM 
Human 
episodic 
memory
NEU Neuroticism SLE 
Systemic Lupus 
Erythematosus 
BPAS 
Blood 
pressure and 
arterial 
stiffness 
HIV1 
HIV-1 disease 
progression 
OBE 
Obesity-
related traits 
SP Schizophrenia 
CA 
Childhood 
asthma 
HT 
Haematological 
(blood) traits 
PA 
Polysubstance 
addiction 
SPBC 
Sporadic post-
menopausal 
breast cancer 
CAD 
Coronary 
Artery 
Disease 
HYP Hypertension PC 
Prostate 
cancer 
SPM 
Skin 
pigmentation 
CC 
Colorectal 
cancer 
IC Iris color PD 
Parkinson's 
disease
STR Stroke 
CD 
Crohn's 
disease 
IMAN 
Immunoglo
-bulin A 
nephropathy
PF 
Pulmonary 
function 
phenotypes
T1D Type I Diabetes 
CDI Celiac disease IS Ischemic stroke PR Psoriasis T2D Type II Diabetes 
CS 
Coronary 
spasm 
KFET 
Kidney 
function and 
endocrine traits
PSP 
Progressive 
Supranuclear 
Palsy
TG Triglycerides 
CVD 
Cardiovascular
Disease 
outcomes
Table 1. List of diseases and phenotypes considered for this study and the previous study 
(Lewis et al., 2011) with corresponding abbreviations. 
www.intechopen.com
 Meta-Analysis of Genome-Wide Association Studies to Understand Disease Relatedness 
 
203 
(up-regulated, down-regulated, and combined) for the top 200 or 1000 genes were pooled 
for each disease.  All of the genes with significant expression changes were grouped 
together and Jaccard index values were calculated. Gene lists for each disease were 
compared pair-wise for each of the three expression categories. Here, a high Jaccard index 
implied a high degree of commonality between diseases/phenotypes. The Jaccard indexes 
were normalized to produce Z-scores, which were then used as a measure of disease 
relatedness. The significantly changed genes shared by two diseases were also subjected to 
Gene Ontology (GO) term enrichment analysis using the web-based Gene Ontology 
enrichment analysis and visualization (GOrilla) tool (Eden et al., 2007; Eden et al., 2009). 
2.4 Medical subject headings (MeSH) term mapping 
MeSH is the National Library of Medicine’s controlled vocabulary thesaurus (Bodenreider et 
al., 1998). It consists of sets of terms associated with descriptors in a hierarchical structure. 
For the nineteen GEO validation diseases (Table 2), the MeSH trees were downloaded and 
the first level of each tree was used as the disease category. The category that could best 
indicate the cause of the disease was taken as the disease category. 
3. Results 
3.1 Summary of significant disease associations for screening of 61 diseases and 
phenotypes 
Jaccard index values were used to assess similarity between diseases and phenotypes within 
each level of analysis. Correlation between the levels was also assessed using the Spearman 
correlation method. High correlation was seen between the SNP and block data sets, while 
low correlation was seen between the pathway data and the other three levels of analysis. 
The progression from SNP to block, block to gene, and gene to pathway levels resulted in a 
grouping of susceptibility markers. Visualization of the associations by means of DRNs 
suggested the grouping translated to an increase in the strength of associations between 
diseases. This was also reflected in the distribution of Jaccard indexes for each level. Figure 1 
shows a slight distribution shift to the right from SNP level to pathway level. 
The DRNs suggested consistent association between several diseases for the SNP, block, and 
gene levels. The strongest associations seen for all populations were observed between 
(multiple sclerosis [MS], T1D, and RA), with noticeable association between (haematological 
traits [HT] and adult fetal hemoglobin levels [HBF]) and (serum low-density 
lipopolysaccharide cholesterol levels [SLCL] and lipid measurements [LM]). Several other 
less significant associations were suggested by the DRNs as well, but these associations were 
not consistent in significance for all populations. The qualitative assessments made by 
examining the DRNs were verified using PCA, which allowed for quantitative isolation of 
the strongest relationships. The PCA results matched the visual assessment for all levels, 
and suggested additional strong associations unique to specific populations were present. 
For example, an association between (LM and triglyceride levels [TG]) that was unique to 
the JPT population was suggested that was not outwardly apparent by visual inspection of 
the DRNs. This association was found in the CHB+JPT populations, but not the CHB 
population. JPT was also missing the (HBF and HT) association that was observed in the 
other populations. Further details regarding the results of this portion of the study were 
previously submitted for publication (Lewis et al., 2011). 
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Disease platform 
GEO 
record 
Sample Size 
MeSH category 
Disease Control
AD GPL96 GSE1297 22 9 
Nervous System Diseases [C10] 
Mental Disorders [F03] 
ALS GPL96 and 97 GSE3307 9 16 
Nervous System Diseases [C10] 
Nutritional and Metabolic Diseases 
[C18] 
BD GPL96 GSE5388 30 31 Mental Disorders [F03] 
BC GPL96 and 97 GSE6883 6 3 
Neoplasms [C04] 
Skin and Connective Tissue Diseases 
[C17] 
CD GPL96 GSE3365 59 42 Digestive System Diseases [C06] 
IS GPL96 GSE1869 6 10 Cardiovascular Diseases [C14] 
OBE GPL96 GSE474 16 8 
Nutritional and Metabolic Diseases 
[C18] 
PD GPL96 GSE6613 50 22 Nervous System Diseases [C10] 
PR GPL96 GSE6710 13 13 
Skin and Connective Tissue Diseases 
[C17] 
SLE GPL96 and 97 GSE11909 103 12 
Skin and Connective Tissue Diseases 
[C17] 
Immune System Diseases [C20] 
CAD GPL96 GSE12288 110 120 Cardiovascular Diseases [C14] 
T1D GPL570 GSE10586 12 15 
Nutritional and Metabolic Diseases 
[C18] 
Endocrine System Diseases [C19] 
Immune System Diseases [C20] 
T2D GPL96 and 97 GSE9006 12 24 
Nutritional and Metabolic Diseases 
[C18] 
Endocrine System Diseases [C19] 
CA GPL570 GSE8052 268 136 
Respiratory Tract Diseases [C08] 
Immune System Diseases [C20] 
CC GPL570 GSE9348 70 12 
Neoplasms [C04] 
Digestive System Diseases [C06] 
ND GPL570 GSE11208 6 5 
Disorders of Environmental Origin 
[C21] 
Mental Disorders [F03] 
SP GPL570 GSE4036 14 14 Mental Disorders [F03] 
AF GPL96 and 97 GSE2240 10 5 Cardiovascular Diseases [C14] 
PSP GPL96 GSE6613 6 22 
Nervous System Diseases [C10] 
Eye Diseases [C11] 
Table 2. List of nineteen diseases in gene expression analysis and their MeSH classification. 
3.2 Clustering of genetic associations 
Based on the observations made using the DRNs, agglomerative hierarchical clustering was 
used to find groups of diseases. At each level, the 61 diseases/phenotypes were clustered 
into ten groups. The number of clusters was set to ten based on visual inspection of the  
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Fig. 1. Graphical representation of histogram data showing distribution of all Jaccard 
indexes for all populations at each level of analysis. Index values were grouped and then 
divided into twenty bins across the range zero to one. (N = 9150 for each analysis level) 
hierarchical branching of the trees. Representative clustering results are shown for the 
CHB+JPT population in Figure 2. The CHB+JPT population showed a high correlation to 
most populations at all levels of analysis based on the Rand Index for similarity. The Rand 
Index for similarity was used to compare the clustering across populations at each level. The 
diseases within each cluster were least similar at the SNP level for all populations and most 
similar at the gene level across most of the populations. At the SNP level groupings, 
associations between (MS, RA, and T1D), (HBF and HT), and (breast cancer [BC] and 
sporadic post-menopausal breast cancer [SPBC]) were found for all populations (Figure 2A). 
The grouping of (RA and T1D), (BC and SPBC), (HBF and HT), (Amyotrophic Lateral 
Sclerosis [ALS] and Parkinson’s disease [PD]) and (colorectal cancer [CC] and prostate 
cancer [PC]) were consistent at the block level for all populations (Figure 2B). At the gene 
level, the number of diseases/phenotypes included in each cluster increased with consistent 
groups again observed for all populations. These groups included (MS, RA, and T1D), (ALS, 
PD, CAD, Alzheimer’s disease [AD] and T2D), and (neuroticism [NEU], brain aging [BA], 
and sleep and circadian phenotypes [SCP]) (Figure 2C). Clusters at the pathway level were 
also much larger than at the other levels. No consistent relationships were seen for the 
clusters containing a larger number of diseases, but the smaller groupings consistently 
showed relationships between (longevity and age-related phenotypes [LONG] and early 
onset extreme obesity [EO]), (cardiovascular disease outcomes [CVD], CD, and NEU) and 
(blood lipids [BL], LM, and Restless Leg Syndrome [RLS]) (Figure 2D). Four populations 
suggested clustering of (LONG, EO, and T1D), while one, YRI, showed a relationship 
between (LONG, EO, and SLCL). 
3.3 Gene expression analysis 
The gene expression profiles showed some patterns for the three expression categories (up-
regulated, down-regulated, and combined), with the number of strong associations 
increasing with cutoff type (top 200 most changed genes, top 1000 most changed genes, and 
changes with a p-value less than 0.05). Jaccard indexes for each disease/phenotype pair 
were calculated and used to construct DRNs, which are shown in Figure 3. Strong 
associations between (PD, Progressive Supranuclear Palsy [PSP], and nicotine dependence 
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[ND]), (ischemic stroke [IS], CC, and CD), and (CAD and childhood asthma [CA]) were 
observed under all three cutoff scenarios for all three expression categories of analysis. Of 
these, the (CAD and CA) pair showed the most variation in association strength for all the 
variables considered. 
 
 
Fig. 2. Clustering dendrogram for 61 disease/phenotype comparisons at the (A) SNP, (B) 
block, (C) gene, and (D) pathway levels. Colored boxes indicate the clusters derived from 
Rand Index analysis. Results for the CHB+JPT population are shown as a representative 
data set for all populations. 
Links between disease classifications were also seen. Connections between nervous system 
diseases and disorders of environmental origin (i.e., (PSP and ND) and (PD and ND)) were 
seen in all three expression categories and cutoff types. Associations between nervous 
system and mental disorders (e.g., AD and BD) were seen for the top 200 and top 1000 
groups, but this association was masked in the p-value-derived group. For the p-value 
group, predominate associations between metabolic, cardiovascular, digestive, and immune 
system diseases were found. One unexpected classification association was the nervous 
system-metabolic disease link exemplified by (PSP and OBE) and (PD and OBE) for the 
down-regulation and subsequently combined expression groups with the top 1000 and p-
value cutoffs. 
As expected, the number of significant associations increased as the threshold criteria 
increased given that the quantity of data available for comparison was greater. Seemingly 
strong associations observed at the top 200 cutoff, such as the (AD and BD) and (BD and SP) 
associations were masked in the p-value cutoff data as other stronger associations were 
present. The increase in maximum Jaccard index for the combined expression data set from 
0.44 to 0.81 agreed with this observation. Though we saw an increase in relationship 
strength with less stringent cutoff thresholds, the additional comparison data resulted in 
reduction in significant associations. Therefore, the expression categories for the p-value 
cutoff group were used to compare with the SNP-based data in order to avoid assigning an 
arbitrary cutoff for the expression data and to ensure enough data was available for the 
nineteen-disease comparison. 
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3.4 Comparison of the SNP and expression data for nineteen diseases 
Correlation between data sets may have been influenced by the data sources. Both the SNP 
and block levels encompassed data from the HapMap site. The gene level data was obtained 
by cross referencing the HapMap data against the Ensembl database of gene names. The 
pathway data was obtained by cross referencing the Ensembl-derived data against the 
KEGG database. Given that the amount of data available through each of these sources is 
not consistent, there was loss of data in the transition from blocks to genes and genes to 
pathways. Of the reduced set of nineteen diseases and phenotypes compared, only atrial 
fibrillation/atrial flutter (AF) did not contain gene data for the SNP-based comparisons. The 
number of missing diseases/phenotypes increased to four at the pathway level (i.e., AF, CA, 
psoriasis [PR], and PSP). Despite the missing disease associations for AF, the gene level of 
analysis was used for comparison to the expression data. The range of Z-scores for this 
dataset was closest to the range seen for the expression data, and intuitively, the gene data 
should show some correlation to gene expression. 
 
 
 
 
Fig. 3. DRNs for expression data for the three cutoff levels (top 200, top 1000, and 
significance with p-value < 0.05) and three expression categories (up-regulated, down-
regulated, and combined). Disease nodes are color coded to show grouping of diseases 
based on MeSH classification. Edges are color coded according to increasing strength of 
disease association. Values for the color scale are listed in the inserted table. 
DRNs comparing the gene level of analysis for the CEU, CHB+JPT, and YRI populations to 
the expression data are shown in Figure 4. The JPT and CHB populations are not shown 
since the CHB+JPT population is highly representative of the individual populations. A 
Spearman correlation was calculated between each population for the SNP-based data set 
and the expression data (Table 3). A weak negative correlation was observed between the 
genetic and expression data, suggesting no significant relationships were shared between 
the two data sets. A qualitative analysis of the networks and clustering from the SNP-based 
data analysis suggested a high degree of similarity between the predicted associations for all 
population. However, the strong associations observed in the genetic analysis were not seen 
in the expression data. Rather, a seemingly reciprocal relationship appeared between the 
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genetic and expression DRNs. The strongest expression-based association was between ALS 
and obesity-related traits (OBE), which was in the weakest associations group for the SNP-
based associations. An examination of the genetic DRNs suggested the strongest 
associations between (ALS and PD), (AD and T2D), and (T1D and SLE). These associations 
were weak for the expression data. Some associations near the middle of the Z-score range 
appeared more common between the data sets, such as the (IS and CC), (AD and BD), and 
(OBE and CC) pairs. 
Table 3. Spearman correlation coefficients between populations and between each 
population and the GEO data. The Spearman correlation is a comparison of the ranked Z-
scores for each data set. 
Despite the overall lack of correlation between the genetic and expression analyses, several 
unexpected links between neurological and cardiovascular/metabolic diseases were observed 
in both data sets (i.e., (AD and T2D) and (PD and OBE)). These potentially novel disease 
relationships may primarily rely on genetic similarity or genomic expression similarity instead 
of phenotypic classification, but this idea would need to be further explored. 
 
 
Fig. 4. DRNs based on Z-scores for three populations and expression data. DRNs for (A) 
combined expression data for significantly changed genes (p<0.05), (B) CEU gene level, (C) 
CHB+JPT gene level, and (D) YRI gene level are shown. Edge live color and width 
correspond to strength of association between disease pairs. The gradient and 
corresponding values are listed in the inserted table. 
 
61 diseases CEU CHB JPT CHB+JPT YRI 
CEU 1 0.9599 0.9595 0.9574 0.9447 
CHB   1 0.9779 0.9925 0.9726 
JPT     1 0.9858 0.9556 
CHB+JPT       1 0.9686 
YRI         1 
            
19 diseases           
GEO -0.1367 -0.1228 -0.1278 -0.1254 -0.1176 
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4. Discussion 
The results from this study suggested it is possible to elucidate genetic similarities that can 
be overlooked during single disease GWAS. Several expected associations supported by 
literature were found (e.g. association between (SLE and RA) and (EO and SLCL)) while 
some unexpected associations were also observed. The unexpected neurological-
cardiovascular/metabolic disease associations were observed for both the genetic analysis 
and the expression profile analysis. Though the origin and symptoms associated with 
diseases in each category may be different, the results suggest genetic similarities. Possible 
explanations for these associations cannot be elucidated solely from this study given the 
broad nature of the comparison. A detailed SNP-by-SNP and gene-by-gene examination 
may indicate the reason behind the neurological-cardiovascular/metabolic relatedness. 
Those relationships are particularly interesting and may indicate some common underlying 
molecular mechanism among these disease groups that has not yet been widely studied.  
Clinical evidence supports the strongest relationships identified from the expression data. 
PSP and PD share some common symptoms such as stiffness, and movement difficulties 
which could explain the common expression pattern indicating some degree of relatedness 
between the two. On the other hand, explaining the relationship between PSP and ND is 
more difficult. Several studies have shown that smokers have a lower risk of developing 
Parkinson’s disease (Soto-Otero et al., 1998; Hernan et al., 2001; Quik, 2004). One recently 
published paper showed that smoking for a greater number of years may reduce the risk of 
the disease (Chen et al., 2010). An earlier study suggested that younger patients with CD 
might be under an increased risk of IS (Andersohn et al., 2010). Extensive studies have 
demonstrated a strong association between CD and CC (Gillen et al., 1994). The relationship 
between (IS and CC) and (CAD and CA) is also unclear, but shared immune-dependent 
responses may be the common link.  
Similarities and differences were observed between the three categories (up-regulated, 
down-regulated and combined) of gene expression analysis (see Figure 3). The different 
association patterns may be due to the use of a single rule to identify disease associated 
genes for all kinds of diseases, which over simplifies the problem. Theoretically, variance of 
gene expression can be considered as a quantitative trait inherited from genetic variation. It 
is possible that a combined DNA variant and expression phenotype can better explain 
genetic architecture with reduced environmental and biological noise (Dermitzakis, 2008). 
However, the precise and reliable estimation of molecular link between functional genomic 
effects and complex organism phenotypes depends on a large number of pooled variant and 
gene expression data from corresponding tissues or cell types, since tissue-specific 
differences can be found widely (Dermitzakis, 2008). A combined genetic and gene 
expression profile study, as presented here, can shed light on disease relatedness from 
different perspectives. Parikh et al. performed a more direct comparison of GWAS and 
expression data in an effort to prioritize T2D susceptibility genes (Parikh et al., 2009). The 
group isolated SNPs from GWAS, searched for associated genes, and then found 
corresponding tissue-specific expression profiles for a subset of all the SNP-associated genes 
(Parikh et al., 2009). Parikh et al. were able to identify five genes common to individuals 
with T2D and twelve genes with differentiating expression patterns in individuals with 
versus without the disease (Parikh et al., 2009). Rather than focusing on a single disease to 
identify targets, we strove for a more global comparison of genetic and expression data. 
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Even though discrepancies between our data sets were observed, it is possible that the 
reduction in data between the gene and pathway level could have excluded some genes 
common to multiple diseases. With the increased density of GWAS and gene expression 
studies, the discrepancies and anomalies observed in this study might be better understood. 
We set out to support the idea that diseases potentially share phenotype similarity as a result 
of genetic factors, pathway associations, expression regulation, or some combination of these 
three ideas. Within the autoimmune disease group, we observed diseases that possessed some 
genetic similarity. We saw expected strong associations between T1D, MS, and RA, as well as 
less expected associations between AD and T2D. It would appear that systemic inflammation 
responses may be the key to shared susceptibility among many of the diseases and phenotypes 
for which we observed relatedness. Clinical studies suggested individuals with one immune-
mediated disease, such as T1D, may be more susceptible to pathogenesis of another (Dorman 
et al., 2003; Nielson et al., 2006; Toussirot et al., 2006; Doran, 2007). It has also been clinically 
suggested that inflammation plays a role in neurological diseases like AD (Akiyama et al., 
2000; Perry, 2004) and PD (Perry, 2004). We also know that cardiovascular and metabolic 
diseases, such as atherosclerosis, T2D, and OBE have links to chronic inflammatory responses 
(Stienstra et al., 2006; Tontonoz&Spiegelman, 2008). In all of these cases, our results suggest the 
clinical manifestations may have genetic relevance and the unexpected 
cardiovascular/neurological links may be important. Given the broad scope of this study, the 
conclusions made here are suggestions for where genetic commonality could be found without 
specific identification of the related targets. A more detailed disease-by-disease analysis 
similar to the study conducted by Parikh et al. (Parikh et al., 2009) would need to be conducted 
to identify specific genes of interest shared by diseases. The methods used in the Parikh et al. 
study can be specifically applied to the study of T1D by performing a detailed step-by-step 
comparison between this disease and other possibly related diseases in order to elucidate 
genetic commonalities to T1D. The results from our study and from one tailored specifically 
for T1D could influence current treatment options and suggest new approaches for managing 
and treating the disease. We feel our study is a strong example of how GWAS and expression 
data can be used conjunctively to predict significant disease associations relevant to improving 
and unifying diagnoses and treatment options for multiple immune-mediated diseases. 
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